Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Anixa Biosciences

NASDAQ ANIX
$2.93 -0.05 -1.71%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 13 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

92.14M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
91.27M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.54
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
31.45M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-24.48 %

Upcoming events Anixa Biosciences

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Anixa Biosciences

Stock analysis Anixa Biosciences

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-8.78 28.42
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
3.79 4.33
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-7.60 9.95
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
0.07 0.65
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-42.64 7.67

Price change Anixa Biosciences per year

1.91$ 8.09$
Min Max

Summary analysis Anixa Biosciences

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Anixa Biosciences

Revenue and net income Anixa Biosciences

All parameters

Stock news Anixa Biosciences

All news
7 December 2023 в 02:34

Anixa Biosciences Shares Climb on Positive Breast Cancer Vaccine Data

7 December 2023 в 02:34

Anixa Biosciences Shares Climb on Positive Breast Cancer Vaccine Data

21 July 2022 в 20:46

Anixa Biosciences Shares Rise 11% After New Patent Allowance

21 July 2022 в 20:46

Anixa Biosciences Shares Rise 11% After New Patent Allowance

30 August 2021 в 19:55

Anixa Biosciences Shares Rise 5% After FDA Approves Cancer Therapy

30 August 2021 в 19:55

Anixa Biosciences Shares Rise 5% After FDA Approves Cancer Therapy

25 August 2021 в 17:20

Anixa Biosciences Shares Rise 10% on Possible Covid-19 Treatment

25 August 2021 в 17:20

Anixa Biosciences Shares Rise 10% on Possible Covid-19 Treatment

18 August 2021 в 22:54

Anixa Biosciences Shares Rise 10% After Patent for Ovarian Cancer Vaccine Technology

About company Anixa Biosciences

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain viral protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was founded in 1982 and is based in San Jose, California.
Address:
3150 Almaden Expressway, San Jose, CA, United States, 95118
Company name: Anixa Biosciences
Issuer ticker: ANIX
ISIN: US03528H1095
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 1987-01-01
Sector: Healthcare
Industry: Biotechnology
Site: https://www.anixa.com

On which stock exchange are Anixa Biosciences (ANIX) stocks traded?

Anixa Biosciences (ANIX) stocks are traded on NASDAQ.

What is the ticker of Anixa Biosciences stocks (ANIX)?

The stock ticker of Anixa Biosciences’s stocks or in other words, the code is ANIX. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Anixa Biosciences (ANIX) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Anixa Biosciences (ANIX) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Anixa Biosciences (ANIX) stocks traded?

Anixa Biosciences (ANIX) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Anixa Biosciences (ANIX) stocks today?

The current price of Anixa Biosciences stocks on 16.05.2024 is 2.93 dollars. per share.

What is the dynamics of Anixa Biosciences (ANIX) stocks from the beginning of the year?

Anixa Biosciences (ANIX) quotes have increased by -25.45% from the beginning of the year up to 2.93 dollars. per 1 stocks.

How much did Anixa Biosciences (ANIX) stocks increase in мае 2024?

This month Anixa Biosciences (ANIX) quotes have increased by -5.18% to 2.93 dollars. per share.

How much are Anixa Biosciences (ANIX) stocks worth?

Today, on October, 16.05.2024 Anixa Biosciences’s (ANIX) stocks cost 2.93 dollars..

What is the market capitalization of Anixa Biosciences (ANIX)?

Capitalization is the market value of Anixa Biosciences (ANIX) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 16.05.2024, the market capitalization of Anixa Biosciences (ANIX) is estimated at about 92136780 dollars.